Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted TherapeuticsBusiness Wire • 08/06/25
Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/28/25
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga • 07/28/25
Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?Zacks Investment Research • 07/24/25
Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 EarningsZacks Investment Research • 07/23/25
Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/21/25
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing WorkflowsBusiness Wire • 06/02/25
RVTY Stock Falls Despite the Latest Launch of Automated InstrumentZacks Investment Research • 05/23/25
Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty TestingBusiness Wire • 05/19/25
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View UpZacks Investment Research • 04/28/25